321 related articles for article (PubMed ID: 26784943)
1. Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs.
Sheng J; Yang YP; Ma YX; Qin T; Hu ZH; Hong SD; Zhou T; Huang Y; Zhao HY; Zhang L
PLoS One; 2016; 11(1):e0147226. PubMed ID: 26784943
[TBL] [Abstract][Full Text] [Related]
2. [Clinical application value of prognostic nutritional index for predicting survival in patients with advanced non-small cell lung cancer].
Xu WJ; Kang YM; Zhou L; Chen FF; Song YH; Zhang CQ
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):146-149. PubMed ID: 28219213
[No Abstract] [Full Text] [Related]
3. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
[TBL] [Abstract][Full Text] [Related]
4. Low pretreatment PNI correlates with worse survival in patients with stage III/IV NSCLC who received chemotherapy.
Shen Y; Li H; Yuan ZQ; Ren MY; Yu SL; Liao YD; Cai JJ; Liu C; Chen BC; Wu AH; Li GF; Xie L
Neoplasma; 2020 Mar; 67(2):394-401. PubMed ID: 31847525
[TBL] [Abstract][Full Text] [Related]
5. The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs.
Zhang Y; Feng YC; Zhu HG; Xiong TC; Hou YS; Song J; Jiang W; Zhu CJ
Medicine (Baltimore); 2018 Jul; 97(30):e11648. PubMed ID: 30045314
[TBL] [Abstract][Full Text] [Related]
6. Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations.
Park S; Park S; Lee SH; Suh B; Keam B; Kim TM; Kim DW; Kim YW; Heo DS
Korean J Intern Med; 2016 Nov; 31(6):1140-1149. PubMed ID: 27017943
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors.
Aguiar-Bujanda D; Dueñas-Comino A; Saura-Grau S; Ros-Sanjuan L; Blanco-Sanchez MJ; Hernandez-Sosa M; Mori-De Santiago M; Galvan-Ruiz S; Lorenzo-Barreto JE; Vargas-Prado AM; Bohn-Sarmiento U
Oncol Res Treat; 2018; 41(12):755-761. PubMed ID: 30419558
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Prognostic Nutritional Index After Surgical Treatment in Lung Cancer.
Okada S; Shimada J; Kato D; Tsunezuka H; Teramukai S; Inoue M
Ann Thorac Surg; 2017 Jul; 104(1):296-302. PubMed ID: 28433217
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis.
Liu HL; Han G; Peng M; Weng YM; Yuan JP; Yang GF; Yu JM; Song QB
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):864-872. PubMed ID: 29270745
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of prognostic nutritional index in advanced (stage IIIB/IV) non-small cell lung cancer patients.
Li XL; Yao ZH; Wan YY; Mou XY; Ni YH; Sun EL; Zhang D; Lin DJ
Neoplasma; 2019 Nov; 66(6):971-977. PubMed ID: 31390870
[TBL] [Abstract][Full Text] [Related]
12. The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: A systematic review and meta-analysis.
Nie W; Tao X; Wei H; Chen WS; Li B
Oncotarget; 2015 Sep; 6(28):25696-700. PubMed ID: 26325082
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases.
Zhang G; Cheng R; Zhang Z; Jiang T; Ren S; Ma Z; Zhao S; Zhou C; Zhang J
Sci Rep; 2017 Feb; 7():42979. PubMed ID: 28211502
[TBL] [Abstract][Full Text] [Related]
14. Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors.
Chen YM; Lai CH; Rau KM; Huang CH; Chang HC; Chao TY; Tseng CC; Fang WF; Chung YH; Wang YH; Su MC; Huang KT; Liu SF; Chen HC; Chang YC; Chang YP; Wang CC; Lin MC
BMC Cancer; 2016 Nov; 16(1):868. PubMed ID: 27821111
[TBL] [Abstract][Full Text] [Related]
15. The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.
Hong S; Zhou T; Fang W; Xue C; Hu Z; Qin T; Tang Y; Chen Y; Ma Y; Yang Y; Hou X; Huang Y; Zhao H; Zhao Y; Zhang L
Tumour Biol; 2015 May; 36(5):3389-97. PubMed ID: 25527156
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer.
Kos FT; Hocazade C; Kos M; Uncu D; Karakas E; Dogan M; Uncu HG; Ozdemir N; Zengin N
Asian Pac J Cancer Prev; 2015; 16(9):3997-4002. PubMed ID: 25987075
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Prognostic Nutritional Index in Patients Undergoing Radical Surgery with Nonsmall Cell Lung Cancer.
Qiu C; Qu X; Shen H; Zheng C; Zhu L; Meng L; Du J
Nutr Cancer; 2015; 67(5):741-7. PubMed ID: 25941961
[TBL] [Abstract][Full Text] [Related]
18. Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations.
Ludovini V; Bianconi F; Pistola L; Pistola V; Chiari R; Colella R; Bellezza G; Tofanetti FR; Siggillino A; Baldelli E; Flacco A; Giuffrida D; Sidoni A; Crinò L
Cancer Chemother Pharmacol; 2012 May; 69(5):1289-99. PubMed ID: 22302407
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
Wang J; Liu Y; Mi X; Shao M; Liu L
Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
[TBL] [Abstract][Full Text] [Related]
20. Exon 19 deletion was associated with better survival outcomes in advanced lung adenocarcinoma with mutant EGFR treated with EGFR-TKIs as second-line therapy after first-line chemotherapy: a retrospective analysis of 128 patients.
Wang Y; Li RQ; Ai YQ; Zhang J; Zhao PZ; Li YF; He WJ; Xia YX; Li WH
Clin Transl Oncol; 2015 Sep; 17(9):727-36. PubMed ID: 26041721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
